DUBLIN--(BUSINESS WIRE)--The "China Patient Monitoring Market - Growth, Trends and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The patient monitoring devices are the devices that are used to measure certain medical parameters by continuously measuring vital signs and/or repeatedly performing medical tests to ensure the well-being of the patient.
In China, chronic diseases like cardiovascular diseases are increasing at a rapid rate. Moreover, the geriatric population of the China is also growing. As a result of these factors, the demand for patient monitoring devices in China has increased over the span of time.
The increased demand has also led to increase in technological advancements in this field which has eased the usage of these devise and also made them, more portable. Moreover, these technologies decrease the number of unnecessary trips to the doctor's office and reduce travel-related expenses. Hence as a result, these devices are also being used for personal use at homes, which has also positively impacted the market growth.
Key Market Trends
Application in Cardiology is expected to Dominate the Market
Cardiac monitoring refers to continuous or intermittent monitoring of heart activity with assessment of the patient's condition relative to their cardiac rhythm. Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment. Continuous cardiovascular and pulmonary monitoring allows for prompt identification and initiation of treatment.
In the recent decade, the incidence of cardiovascular diseases (CVD) in China has increased. As per a 2019 report by Liu S et al., published in JAMA Cardiology 2019, the prevalent cases of CVD have doubled since 1990, reaching nearly 94 million in 2016. The age-standardized prevalence rate of CVD overall has increased significantly from 1990 to 2016 by 14.7%, as did rates for ischemic heart disease (19.1%), ischemic stroke (36.6%), cardiomyopathy and myocarditis (23.1%), and endocarditis (26.7%). Therefore this has increased the prevalence and is expected to increase the demand for patient monitoring devices for cardiology application. Hence this will help in the overall growth of the market.
The patient monitoring market consists of several major players. China has encouraged many global companies to enter the market and as a result, many global players in the patient monitoring market are present in the country. Moreover, some domestic players have also been competing in the Chinese market. These factors have made the region very competitive.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format.
- 3 months of analyst support.
Key Topics Covered:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Chronic Diseases due to Lifestyle Changes
4.2.2 Growth in Geriatric Population
4.2.3 Growing Preference for Home and Remote Monitoring
4.3 Market Restraints
4.3.1 High Cost of Technology
4.3.2 Stringent Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Hemodynamic Monitoring Devices
5.1.2 Neuromonitoring Devices
5.1.3 Cardiac Monitoring Devices
5.1.4 Respiratory Monitoring Devices
5.1.5 Remote Monitoring Devices
5.1.6 Other Types of Devices
5.2 By Application
5.2.4 Fetal and Neonatal
5.2.5 Weight Management and Fitness Monitoring
5.2.6 Other Applications
5.3 By End-users
5.3.1 Home Healthcare
5.3.2 Ambulatory Care Centers
5.3.4 Other End-users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Baxter International Inc
6.1.3 Becton, Dickinson and Company
6.1.4 Boston Scientific Corporation
6.1.5 Draegerwerk AG
6.1.6 GE Healthcare
6.1.7 Johnson & Johnson
6.1.8 Koninklijke Philips NV
6.1.9 Medtronic PLC
6.1.10 Siemens Healthcare GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/cyisp1